These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16634234)

  • 21. Gender differences of sodium metabolism and hyponatremia as an adverse drug effect.
    Grikiniene J; Volbekas V; Stakisaitis D
    Medicina (Kaunas); 2004; 40(10):935-42. PubMed ID: 15516815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam for mood stabilization and maintenance of seizure control following multiple treatment failures.
    Stoner SC; Lea JW; Wolf AL; Berges AA
    Ann Pharmacother; 2005 Nov; 39(11):1928-31. PubMed ID: 16204388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugs.
    Bohn J; Kortepeter C; Muñoz M; Simms K; Montenegro S; Dal Pan G
    Clin Pharmacol Ther; 2015 May; 97(5):508-17. PubMed ID: 25670505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clarithromycin-carbamazepine interaction: neurological symptoms and hyponatremia].
    Alegre Herrera S; Araujo Sanabria J; Rubio Rubio JM
    An Med Interna; 1998 Jan; 15(1):48-9. PubMed ID: 9522506
    [No Abstract]   [Full Text] [Related]  

  • 25. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oxcarbazepine-induced encephalopathy].
    Guilloton L; Drouet A; Renoult PA; Bedubourg G; Vial T; Felten D
    Presse Med; 2003 Sep; 32(28):1323. PubMed ID: 14506441
    [No Abstract]   [Full Text] [Related]  

  • 27. [Safety of medicinal products and reporting of adverse drug reactions].
    Skibicka I; Maciejczyk A
    Neurol Neurochir Pol; 2004; 38(6):503-10. PubMed ID: 15654675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harmonisation in pharmacovigilance.
    Edwards IR; Biriell C
    Drug Saf; 1994 Feb; 10(2):93-102. PubMed ID: 8011183
    [No Abstract]   [Full Text] [Related]  

  • 29. Topiramate-induced metabolic acidosis: a case study.
    Fernández-de Orueta L; Esteban-Fernández J; Aichner HF; Casillas-Villamor A; Rodríguez-Álvarez S
    Nefrologia; 2012 May; 32(3):403-4. PubMed ID: 22592431
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyponatremia due to an additive effect of carbamazepine and clarithromycin.
    Kanbay M; Alkis M; Turgut F; Uz E; Bavbek N; Akcay A
    South Med J; 2007 Feb; 100(2):222. PubMed ID: 17330699
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic acidosis due to topiramate.
    Prescrire Int; 2004 Oct; 13(73):186. PubMed ID: 15499701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP
    Montastruc F; Bagheri H; Lacroix I; Damase-Michel C; Chebane L; Rousseau V; Jouanjus E; Lapeyre-Mestre M; Durrieu G; Montastruc JL
    Drug Saf; 2018 May; 41(5):511-514. PubMed ID: 29270770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative metabolic acidosis induced by chronic topiramate intake in neurosurgical patients.
    Rodriguez L; Valero R; Fàbregas N
    J Neurosurg Anesthesiol; 2008 Jan; 20(1):67-8. PubMed ID: 18157030
    [No Abstract]   [Full Text] [Related]  

  • 34. Promoting adverse drug reaction reporting: comparison of different approaches.
    Ribeiro-Vaz I; Santos CC; Cruz-Correia R
    Rev Saude Publica; 2016; 50():14. PubMed ID: 27143614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyponatremia induced by antiepileptic drugs in patients with epilepsy.
    Lu X; Wang X
    Expert Opin Drug Saf; 2017 Jan; 16(1):77-87. PubMed ID: 27737595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute encephalopathy induced by oxcarbazepine and furosemide.
    Siniscalchi A; Mancuso F; Scornaienghi D; Ferreri G; De Sarro G
    Ann Pharmacother; 2004 Mar; 38(3):509-10. PubMed ID: 14970374
    [No Abstract]   [Full Text] [Related]  

  • 37. The trials and tribulations of pediatric drug trials.
    Shinnar S; Pellock JM
    Neurology; 2005 Nov; 65(9):1348-9. PubMed ID: 16275818
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy.
    Lin CH; Lu CH; Wang FJ; Tsai MH; Chang WN; Tsai NW; Lai SL; Tseng YL; Chuang YC
    Clin Neuropharmacol; 2010; 33(6):293-6. PubMed ID: 20881597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New antiepileptic drugs. II. Clinical use.
    Lee BI
    J Korean Med Sci; 1996 Aug; 11(4):289-304. PubMed ID: 8878797
    [No Abstract]   [Full Text] [Related]  

  • 40. Adverse drug reactions in neonates: could we be documenting more?
    Hawcutt DB; O'Connor O; Turner MA
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):807-20. PubMed ID: 25225053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.